Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Dermata Therapeutics, Inc. - Warrant
No Price
01.05.2026 19:31
Current Prices from Dermata Therapeutics, Inc. - Warrant
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
DRMAW
USD
01.05.2026 19:31
0,02 USD
0,001 USD
+6,67 %
Share Float & Liquidity
Free Float73,15 %
Shares Float498.526,00
Shares Outstanding681.557,00
Company Profile for Dermata Therapeutics, Inc. - Warrant Share
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. It is also developing DMT410 for the treatment of hyperhidrosis and aesthetic conditions. The company was founded in 2014 and is headquartered in San Diego, California.
